WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry. The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable. “The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release. |
China's Shaanxi sees record surge in foreignGreen shift places remote northeastern Chinese city in spotlightInterview: China's economic landscape displays stable, diversified trend: economistThe astonishing effect of stem cell implantsWealthy New Yorkers are ditching idyllic Manhattan townhouses for doormanChina pledges proactive fiscal policy, prudent monetary policy in 2024Chinese C919 jetliner arrives in Singapore to attend airshowChinese carriers allowed to operate more flights to USForeigners' tours in China to be more convenient: ministerREVEALED: The US cities where home prices have DOUBLED the fastest